Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: A nested case-control study

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 7, 2014, Pages 1972-1980

  Lim, Ching Jou ^a   Cheng, Allen C ^a,b,c   Kennon, Jacqueline ^c   Spelman, Denis ^b,c,d   Hale, Dayna ^d   Melican, Gabrielle ^e   Sidjabat, Hanna E ^f   Paterson, David L ^f   Kong, David C M ^a   Peleg, Anton Y ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b Department of Infectious Diseases Alfred Health ^*  (Australia)

^c Infection Prevention and Healthcare Epidemiology Unit Alfred Health   (Australia)

^d Microbiology Department   (Australia)

^e Caulfield Hospital   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Acinetobacter baumannii; Antibiotic resistance; Gram negative bacteria; MRSA; VRE

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIAL COLONIZATION; CASE CONTROL STUDY; CITROBACTER; DECUBITUS; DEMENTIA; ENTEROBACTER; ENTEROBACTER AEROGENES; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MULTIDRUG RESISTANCE; NONHUMAN; NOSE SMEAR; PALLIATIVE THERAPY; PREVALENCE; RISK ASSESSMENT; VANCOMYCIN RESISTANT ENTEROCOCCUS; VERY ELDERLY; BACTERIAL INFECTIONS; CLASSIFICATION; DRUG EFFECTS; GENETICS; GRAM POSITIVE BACTERIUM; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; NOSE MUCOSA; RECTUM;

AGED; AGED, 80 AND OVER; AUSTRALIA; BACTERIAL INFECTIONS; CARRIER STATE; CASE-CONTROL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LONG-TERM CARE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; NASAL MUCOSA; PREVALENCE; RECTUM; RISK ASSESSMENT;

EID: 84902439907     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku077     Document Type: Article

References (46)

1. Pop-Vicas A, Tacconelli E, Gravenstein S et al. Influx of multidrugresistant, Gram-negative bacteria in the hospital setting and the role of elderly patients with bacterial bloodstream infection. Infect Control Hosp Epidemiol 2009; 30: 325-31.
2. Ben-Ami R, Schwaber MJ, Navon-Venezia S et al. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006; 42: 925-34.
3. Lim CJ, McLellan SC, Cheng AC et al. Surveillance of infection burden in residential aged care facilities. Med J Aust 2012; 196: 327-31.
4. March A, Aschbacher R, Dhanji H et al. Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin Microbiol Infect 2010; 16: 934-44.
5. O'Fallon E, Schreiber R, Kandel R et al. Multidrug-resistant Gram-negative bacteria at a long-term care facility: assessment of residents, healthcare workers, and inanimate surfaces. Infect Control Hosp Epidemiol 2009; 30: 1172-9.
6. Pop-Vicas AE, Mitchell SL, Kandel R et al. Multidrug-resistant Gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc 2008; 56: 1276-80.
7. Muto C, Jernigan J, Ostrowsky B et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24: 362-86.
8. Siegel J, Rhinehart E, Jackson M et al. Management of multidrugresistant organisms in health care settings, 2006. Am J Infect Control 2007; 35: S165-93.
9. EUCAST. Breakpoint Tables, Version 1.1, April 2010. http://www.eucast. org (18 March 2013, date last accessed).
10. Réglier-Poupet H, Naas T, Carrer AL et al. Performance of chromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum β-lactamases. J Med Microbiol 2008; 57: 310-5.
11. Franklin C, Liolios L, Peleg A. Phenotypic detection of carbapenemsusceptible metallo-β-lactamase-producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol 2006; 44: 3139-44.
12. Coelho J, Woodford N, Afzal Shah M et al. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother 2006; 50: 756-8.
13. Sidjabat H, Paterson D, Adams Haduch J et al. Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob Agents Chemother 2009; 53: 4733-9.
14. Runnegar N, Sidjabat H, Goh HMS et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J Clin Microbiol 2010; 48: 4051-6.
15. Sidjabat H, Derrington P, Nimmo G et al. Escherichia coli ST131 producing CTX-M-15 in Australia. J Antimicrob Chemother 2010; 65: 1301-3.
16. Turnidge JD, Nimmo GR, Pearson J et al. Epidemiology and outcomes for Staphylococcus aureus bacteraemia in Australian hospitals, 2005-06: report from the Australian Group on Antimicrobial Resistance. Commun Dis Intell Q Rep 2007; 31: 398-403.
17. Xie C, Taylor DM, Howden BP et al. Comparison of the bacterial isolates and antibiotic resistance patterns of elderly nursing home and general community patients. Intern Med J 2012; 42: e157-64.
18. Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-81.
19. O'Fallon E, Pop-Vicas A, D'Agata E. The emerging threat of multidrugresistant Gram-negative organisms in long-term care facilities. J Gerontol A Biol Sci Med Sci 2009; 64: 138-41.
20. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
22. Paquay L, De Lepeleire J, Schoenmakers B et al. Comparison of the diagnostic accuracy of the Cognitive Performance Scale (Minimum Data Set) and the Mini-Mental State Exam for the detection of cognitive impairment in nursing home residents. Int J Geriatr Psychiatry 2007; 22: 286-93.
23. Katz S, Akpom CA. A measure of primary sociobiological functions. Int J Health Serv 1976; 6: 493-508.
24. Flint JA, Ryan P, Gordon DL. Prevalence of MRSA in South Australian nursing homes. Med J Aust 1998; 169: 559-60.
25. Friedewald M, de Wit D. MRSA screening of nursing home residents admitted to hospital on the NSW Central Coast. Australian Infection Control 2001; 6: 119-21.
26. Lasseter G, Charlett A, Lewis D et al. Staphylococcus aureus carriage in care homes: identification of risk factors, including the role of dementia. Epidemiol Infect 2010; 138: 686-96.
27. Snyder G, O'Fallon E, D'Agata EMC. Co-colonization with multiple different species of multidrug-resistant gram-negative bacteria. Am J Infect Control 2011; 39: 506-10.
28. D'Agata E, Mitchell SL. Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med 2008; 168: 357-62.
29. Ben-Ami R, Rodríguez-Baño J, Arslan H et al. A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009; 49: 682-90.
30. Dhanji H, Doumith M, Rooney P et al. Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum β-lactamases in nursing homes in Belfast, UK. J Antimicrob Chemother 2011; 66: 297-303.
31. Segal H, Garny S, Elisha BG. Is IS(ABA-1) customized for Acinetobacter? FEMS Microbiol Lett 2005; 243: 425-9.
32. Mak JK, Kim MJ, Pham J et al. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 2009; 63: 47-54.
33. Furuno JP, Hebden JN, Standiford HC et al. Prevalence of methicillinresistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility. Am J Infect Control 2008; 36: 468-71.
34. Saeed SM, Fakih MGMD, Riederer KB et al. Interinstitutional and intrainstitutional transmission of a strain of Acinetobacter baumannii detected by molecular analysis: comparison of pulsed-field gel electrophoresis and repetitive sequence-based polymerase chain reaction. Infect Control Hosp Epidemiol 2006; 27: 981-3.
35. Stephens C, Francis S, Abell V et al. Emergence of resistant Acinetobacter baumannii in critically ill patients within an acute care teaching hospital and a long-term acute care hospital. Am J Infect Control 2007; 35: 212-5.
36. Maragakis L, Tucker M, Miller R et al. Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures. JAMA 2008; 299: 2513-4.
37. Sengstock DM, Thyagarajan R, Apalara J et al. Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis 2010; 50: 1611-6.
38. Zarrilli R, Pournaras S, Giannouli M et al. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 2013; 41: 11-9.
39. O'Fallon E, Kandell R, Schreiber R et al. Acquisition of multidrug-resistant Gram-negative bacteria: incidence and risk factors within a long-term care population. Infect Control Hosp Epidemiol 2010; 31: 1148-53.
40. van der Mee-Marquet N, Savoyen P, Domelier-Valentin AS et al. CTX-M-type fluoroquinolone-resistant Escherichia coli: analysis of the colonization of residents and inanimate surfaces 1 year after a first case of urinary tract infection at a nursing home in France. Infect Control Hosp Epidemiol 2010; 31: 968-70.
41. Wingard E, Shlaes JH, Mortimer EA et al. Colonization and cross-colonization of nursing home patients with trimethoprim-resistant Gram-negative bacilli. Clin Infect Dis 1993; 16: 75-81.
42. Brugnaro P. Clustering and risk factors of methicillin-resistant Staphylococcus aureus carriage in two Italian long-term care facilities. Infection 2009; 37: 216-21.
43. Eveillard M, Charru P, Rufat P et al. Methicillin-resistant Staphylococcus aureus carriage in a long-term care facility: hypothesis about selection and transmission. Age Ageing 2008; 37: 294-9.
44. Rooney PJ, O'Leary MC, Loughrey AC et al. Nursing homes as a reservoir of extended-spectrum β-lactamase (ESBL)-producing ciprofloxacinresistant Escherichia coli. J Antimicrob Chemother 2009; 64: 635-41.
45. Muder RR, Brennen C, Wagener MM et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991; 114: 107-12.
46. Mulhausen PL, Harrell LJ, Weinberger M et al. Contrasting methicillin-resistant Staphylococcus aureus colonization in Veterans Affairs and community nursing homes. Am J Med 1996; 100: 24-31.